Document is current
Any future updates will be listed below
-
Authors
Ma, Chong https://orcid.org/0000-0002-5054-9259
Du, Jiejun
Lan, Lan
Kapoor, Archana
Marc, Gonzalo Perez
Jimenez, Gilberto
Duncan, Christopher J. A.
Le Cam, Nancy
Lin, Nina
Priddy, Frances
Garg, Sanjay
Stoszek, Sonia K.
Shaw, Christine A.
Goswami, Jaya
Wilson, Eleanor
Das, Rituparna
Zhou, Honghong
Zheng, Lingyi https://orcid.org/0000-0002-3446-3447
-
Funding
Funding for this research was provided by:
This work was supported by Moderna, Inc. Funding to pay the Open Access publication charges for this article was provided by Moderna, Inc.
- License Information
-
More Information
Article History
Received: 6 December 2024
Accepted: 13 June 2025
First Online: 3 July 2025
Competing interests
: C.M., J.D., L.L., A.K., N.L.C., N.L., F.P., S.G., S.K.S., C.A.S., J.G., E.W., R.D., H.Z., and L.Z. are employees of Moderna, Inc., and may hold stock/stock options in the company. C.J.A.D. acts on behalf of Newcastle upon Tyne Hospitals NHS Foundation Trust as an investigator on clinical trials sponsored by manufacturers of vaccines and antimicrobials, including Moderna, AstraZeneca, Synairgen, Janssen, and Valneva, and has received no personal financial payment for this work. C.J.A.D. has provided consultative advice to Synairgen on behalf of Newcastle University. G.P.M. has received a research grant from Merck and conducts clinical trials for Pfizer, Sanofi, and Moderna, Inc. G.J. has no conflicts to disclose.
